PAVmed Inc (PAVM): Next-Year EPS Estimate 59.24%
As of 2026-06-04, PAVmed Inc (PAVM) has a next-year EPS growth estimate of 59.24%.
On 2026-05-19, analyst consensus for PAVM's next-year EPS growth shifted from 59.19% to 59.24% — a positive change of 0.05 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at 44.23%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 59.24%
- EPS growth this year
- 44.23%
- EPS next quarter (est)
- -$0.47
- Last price
- $5.45
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 59.24% | 44.23% | -$0.47 | $5.45 |
| 2026-06-03 | 59.24% | 44.23% | -$0.47 | $5.84 |
| 2026-06-02 | 59.24% | 44.23% | -$0.47 | $6.00 |
| 2026-06-01 | 59.24% | 44.23% | -$0.47 | $6.15 |
| 2026-05-31 | 59.24% | 44.23% | -$0.47 | $6.20 |
| 2026-05-28 | 59.24% | 44.23% | -$0.47 | $6.27 |
| 2026-05-27 | 59.24% | 44.23% | -$0.47 | $6.30 |
| 2026-05-26 | 59.24% | 44.23% | -$0.47 | $6.14 |
| 2026-05-25 | 59.24% | 44.23% | -$0.47 | $6.39 |
| 2026-05-24 | 59.24% | 44.23% | -$0.47 | $6.39 |
| 2026-05-21 | 59.24% | 44.23% | -$0.47 | $6.35 |
| 2026-05-20 | 59.24% | 44.23% | -$0.47 | $6.10 |
| 2026-05-19 | 59.24% | 44.23% | -$0.47 | $6.40 |
| 2026-05-18 | 59.19% | 44.15% | -$0.47 | $6.21 |
| 2026-05-17 | 34.94% | 52.22% | -$0.67 | $6.53 |
| 2026-05-14 | 34.94% | 52.22% | -$0.70 | $6.45 |
| 2026-05-13 | 34.94% | 52.22% | -$0.70 | $6.56 |
| 2026-05-12 | 34.94% | 52.22% | -$0.70 | $6.50 |
| 2026-05-11 | 34.94% | 52.22% | -$0.70 | $6.75 |
| 2026-05-10 | 34.94% | 52.22% | -$0.70 | $7.16 |
| 2026-05-07 | 34.94% | 52.22% | -$0.70 | $7.14 |
| 2026-05-06 | 34.94% | 52.22% | -$0.70 | $7.01 |
| 2026-05-05 | 34.94% | 52.22% | -$0.70 | $8.05 |
| 2026-05-04 | 34.94% | 52.22% | -$0.70 | $8.13 |
| 2026-05-03 | 34.94% | 52.22% | -$0.70 | $8.53 |
| 2026-04-30 | 34.94% | 52.22% | -$0.70 | $8.30 |
| 2026-04-29 | 34.94% | 52.22% | -$0.70 | $8.92 |
| 2026-04-28 | 34.94% | 52.22% | -$0.70 | $8.94 |
| 2026-04-27 | 34.94% | 52.22% | -$0.70 | $8.40 |
| 2026-04-26 | 34.94% | 52.22% | -$0.70 | $9.00 |
Recent News
- PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ...GuruFocus.com
- PAVmed Provides Business Update and Reports First Quarter 2026 Financial ResultsPR Newswire
- PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Growth InitiativesGuruFocus.com
- PAVmed Inc (PAVM) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Growth InitiativesGuruFocus.com
- PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsPR Newswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is PAVmed Inc's next-year EPS growth estimate?▾
As of 2026-06-04, PAVmed Inc (PAVM) has a next-year EPS growth estimate of 59.24%, based on analyst consensus.
When was the latest EPS estimate revision for PAVM?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 59.19% to 59.24%.
What sector and industry does PAVmed Inc belong to?▾
PAVmed Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PAVM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. PAVmed Inc (PAVM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports